The Disrupters
Skirting the law for more than five years gave this company a huge advantage, enabling it to gobble up market share, so that now as the dominant player, it can use its size to power long-term growth.
Skirting the law for more than five years gave this company a huge advantage, enabling it to gobble up market share, so that now as the dominant player, it can use its size to power long-term growth.
The distressed-bond universe exhibits a rare market condition that in the past has produced an average annual return of 73%. On the face of it, as we discuss in this issue, this condition could prove to be an excellent time to be buying distressed debt.
While non-standard insurance policies guard against high-risk events – like Kiss’ Gene Simmons hurting his tongue or Bruce Springsteen losing his voice – this doesn’t necessarily make for a riskier business model as we show with this highly profitable company that is eating up market share.
With the share price down and with a handful of catalysts likely to drive the price higher, we provide an update on V.F. Corporation – and look at three other stocks in the portfolio as well: OneSpan, Orthofix Medical, and Mercury Systems.
Non-bank direct lenders, which normally concentrate on small-to-medium enterprises, are now playing in the big leagues. A big question is whether these non-traditional lenders will continue to keep a lid on defaults when the U.S. economy eventually hits a rough patch.
Non-bank direct lenders, which normally concentrate on small-to-medium enterprises, are now playing in the big leagues. A big question is whether these non-traditional lenders will continue to keep a lid on defaults when the U.S. economy eventually hits a rough patch.
The biotech company we recommend in this issue has a solid balance sheet and features more potential catalysts to success than many other biotech opportunities. These characteristics make it particularly well-suited to the investing environment we find ourselves in today.
This issue is devoted to an expanded portfolio review – looking at five of our holdings that are finding ways to win in the current stagflationary environment in the U.S. economy.
Non-bank direct lenders, which normally concentrate on small-to-medium enterprises, are now playing in the big leagues. A big question is whether these non-traditional lenders will continue to keep a lid on defaults when the U.S. economy eventually hits a rough patch.
This company is a leading manufacturer of electrical components used in construction and manufacturing – and stands to benefit from the more than $2 trillion of infrastructure funds being poured into projects across the U.S.